Company Overview and News

 
Tata Consultancy Services' (TTNQY) CEO Rajesh Gopinathan on Q4 2018 Results - Earnings Call Transcript

1h seekingalpha
Tata Consultancy Services, Ltd. ADR (OTCPK:TTNQY) Q4 2018 Earnings Conference Call April 19, 2018 9:30 AM ET
Upvote Downvote

 
Tata Sons appoints Nupur Mallick as new group chief HR officer

8h livemint
Mumbai: Salt to software conglomerate Tata Sons on Thursday said it appointed Nupur Mallick as the group’s chief human resource officer.
Upvote Downvote

 
TCS Q4: Investments in digital paying off, BFSI challenges to end next fiscal

9h moneycontrol
Tata Consultancy Services, the country’s largest information technology services exporter on Thursday said its investments in digital were paying off, and challenges in its largest businesses- banking, financial services and insurance and retail- will not continue into the next financial year.
Upvote Downvote

 
TCS Q4 profit rises 4.5% to Rs6,904 crore, beats market expectations

12h livemint
Mumbai: Tata Consultancy Services Ltd (TCS), India’s biggest software services exporter, reported a 4.5% rise in Q4 profit on Thursday, beating market expectations.
Upvote Downvote

 
Tata Consultancy Services Limited - Financial Result Updates

12h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Tata Consultancy Services Limited - Bonus

12h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Tata Consultancy Services Limited - Outcome of Board Meeting

12h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Tata Consultancy Services Limited - Dividend

12h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Tata Consultancy Services Limited - Dividend

12h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Market Update: Hindalco, Vedanta jump 7% as CNX Metal outperforms; UltraTech, Yes Bank top gainers

15h moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 29 points was trading at 10,555 while the Sensex was up 63 points or 0.18 percent.
Upvote Downvote

 
Tata Sons appoints Nupur Mallick as new Group Chief Human Resource Officer

16h moneycontrol
Tata Sons, the promoter of major operating companies of the Tata group, today announced appointment of Nupur Mallick as the new Group Chief Human Resource Officer.
Upvote Downvote

 
Market Update: Metal stocks outshine as NALCO, Hindustan Copper jump 9-12%; HUL hits new 52-week high

17h moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 33 points was trading at 10,560 while the Sensex was up 65 points or 0.19 percent.
Upvote Downvote

 
Market Update: CNX metal outperforms led by Hindustan Copper; TCS trades in green, Hindalco jumps 4%

19h moneycontrol
The Indian equity market was trading on a positive note on Thursday morning with the Nifty gaining 28 points was trading at 10,554 while the Sensex was up 76 points or 0.22 percent.
Upvote Downvote

 
Will TCS better street expectations?

2018-04-18 thehindubusinessline
Tata Consultancy Services will declare results for Q4 and full-year ended March 2018 on Thursday. Though Infosys posted results on expected lines, its shares fell close to 4 per cent since the results, as the company lowered its margin guidance to 22-24 per cent for FY19 from 23-25 per cent in FY18. Most analysts expect TCS’ results to be better than Infosys. Analysts also expect the largest market-cap company to announce a margin guidance of over 25 per cent.
Upvote Downvote

 
Markets await TCS Q4 earnings on April 19; Here#39;s what to watch for

2018-04-18 moneycontrol
Tata Consultancy Services, India’s largest IT services exporter, will announce its fourth quarter and annual results on Thursday, nearly a week after its closest rival Infosys forecast margins that disappointed investors.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...